TBC1D3E
gene geneOn this page
Summary
TBC1D3E (TBC1 domain family member 3E, HGNC:27071) is a protein-coding gene on chromosome 17q12, encoding TBC1 domain family member 3E (A0A087X179). Acts as a GTPase activating protein for RAB5.
Predicted to enable GTPase activator activity. Predicted to be located in plasma membrane.
Source: NCBI Gene 102723859 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001291466
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27071 |
| Approved symbol | TBC1D3E |
| Name | TBC1 domain family member 3E |
| Location | 17q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000278599 |
| Ensembl biotype | protein_coding |
| OMIM | 610808 |
| Entrez | 102723859 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000621587
RefSeq mRNA: 1 — MANE Select: NM_001291466
NM_001291466
CCDS: CCDS77009
Canonical transcript exons
ENST00000618095 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 102 present calls, max score 76.89.
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.89 | gold quality |
| mucosa of stomach | UBERON:0001199 | 75.31 | gold quality |
| bone marrow cell | CL:0002092 | 44.38 | gold quality |
| gall bladder | UBERON:0002110 | 44.32 | gold quality |
| bone marrow | UBERON:0002371 | 42.06 | gold quality |
| tonsil | UBERON:0002372 | 40.91 | silver quality |
| fundus of stomach | UBERON:0001160 | 40.64 | gold quality |
| blood | UBERON:0000178 | 38.98 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.70 | silver quality |
| lymph node | UBERON:0000029 | 37.49 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.06 | gold quality |
| left testis | UBERON:0004533 | 35.47 | gold quality |
| testis | UBERON:0000473 | 35.18 | gold quality |
| right uterine tube | UBERON:0001302 | 33.55 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 33.50 | gold quality |
| liver | UBERON:0002107 | 33.03 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 32.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 32.15 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| cerebellar cortex | UBERON:0002129 | 32.07 | gold quality |
| cerebellum | UBERON:0002037 | 32.06 | gold quality |
| urinary bladder | UBERON:0001255 | 32.04 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.78 | gold quality |
| muscle of leg | UBERON:0001383 | 30.67 | gold quality |
| left uterine tube | UBERON:0001303 | 30.62 | gold quality |
| kidney | UBERON:0002113 | 30.23 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting TBC1D3E, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-12130 | 99.75 | 65.47 | 452 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-3940-5P | 99.14 | 65.26 | 493 |
| HSA-MIR-4507 | 99.14 | 65.27 | 515 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-8060 | 98.61 | 66.93 | 1187 |
| HSA-MIR-5585-5P | 97.95 | 68.80 | 1024 |
| HSA-MIR-3135A | 96.41 | 65.30 | 494 |
| HSA-MIR-548AD-3P | 94.39 | 66.04 | 350 |
Cross-species orthologs
0 orthologs
Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D13 (ENSG00000107021), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), GRTP1 (ENSG00000139835), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), SGSM1 (ENSG00000167037), TBC1D21 (ENSG00000167139), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3K (ENSG00000273513), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512)
Protein
Protein identifiers
TBC1 domain family member 3E — A0A087X179 (reviewed: A0A087X179)
All UniProt accessions (1): A0A087X179
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a GTPase activating protein for RAB5. Does not act on RAB4 or RAB11.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in pancreas, thymus and testis.
Post-translational modifications. Ubiquitinated by a CUL7-based E3 ligase, which leads to proteasomal degradation. Palmitoylation is required for membrane localization and protects TBC1D3 from ubiquitination.
Miscellaneous. TBC1D3 is encoded by a collection of very similar paralogs with multiple copies of each paralog, some human genomes encoding well over 50 copies depending on ethnic origin of the donor.
RefSeq proteins (1): NP_001278395* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000195 | Rab-GAP-TBC_dom | Domain |
| IPR035969 | Rab-GAP_TBC_sf | Homologous_superfamily |
| IPR050302 | Rab_GAP_TBC_domain | Family |
Pfam: PF00566
UniProt features (6 total): lipid moiety-binding region 2, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A087X179-F1 | 60.44 | 0.25 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 318, 325
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 8 (showing top):
GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, chr17q12, GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY, WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME, GOCC_ENDOSOME, GOMF_GTPASE_ACTIVATOR_ACTIVITY
GO Biological Process (0):
GO Molecular Function (1): GTPase activator activity (GO:0005096)
GO Cellular Component (3): endosome (GO:0005768), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
10 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBC1D3E | ADHFE1 | Q8IWW8 | 322 |
| TBC1D3E | RDH5 | Q92781 | 270 |
| TBC1D3E | GPR32 | O75388 | 0 |
| TBC1D3E | ERVFRD-1 | P60508 | 0 |
| TBC1D3E | CCDC7 | Q96M83 | 0 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| M | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A6NDS4, A6NER0, A6QPT6, B9A6J9, M3WHG5, O14771, O15482, O15553, O19110, O76081, P0C7X1, P0C7X3, P0C7X4, P35125, P48778, P48967, P79209, Q13670, Q15697, Q2TBC4, Q3T191, Q3UZD7, Q4R2Z8, Q5DRQ5, Q5SSQ6, Q5XFX8, Q69ZB3, Q6DHY5, Q6IPX1, Q6ZMN8, Q8BLR5, Q8BWA8, Q8IYF1, Q8IZP1, Q8JZW5, Q8N7G0
Diamond homologs: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A2AWA9, A6H6A9, A6NDS4, A6NER0, B9A6J9, H2KZZ6, P0C7X1, P35125, Q2M2D7, Q5RAN1, Q5SVR0, Q66K14, Q6DHY5, Q6IPX1, Q80XC3, Q86UD7, Q8IZP1, Q92738, Q9UFV1, Q9Y3P9, A3KGB4, A6QP29, B0R0W9, B7ZAP0, O60343, O60447, O95759, O97790, P58802, P97366, Q0IIM8, Q10496, Q12317, Q12344, Q28CB1, Q3UYK3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS111549784 (17:38124224 T>A), RS111638343 (17:38123005 A>C,G,T), RS111660355 (17:38125216 T>G), RS112933293 (17:38122554 A>G), RS11550750 (17:38132229 T>A), RS1156353835 (17:38135058 G>A), RS1156489671 (17:38135111 C>T), RS1156720073 (17:38136860 C>T), RS1156855602 (17:38126674 C>G,T), RS1157054282 (17:38123793 G>T), RS1157167244 (17:38133541 G>A), RS1157458146 (17:38127888 C>A), RS1157772065 (17:38133879 T>G), RS1157789417 (17:38124503 A>G), RS1157853376 (17:38128463 A>G)
Disease associations
OMIM: gene MIM:610808 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| 2-methyl-4-isothiazolin-3-one | decreases expression | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.